Dyne Therapeutics Inc.

NASDAQ: DYN · Real-Time Price · USD
12.11
-0.22 (-1.78%)
At close: Aug 19, 2025, 11:11 AM

Dyne Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-6.99 -3.36 -3.65 -4.05
PEG Ratio
0.48 -0.14 -0.43 -0.03
PS Ratio
n/a n/a n/a n/a
PB Ratio
3.52 8.70 2.39 1.64
P/FCF Ratio
-7.53 -4.2 -3.84 -4.91
P/OCF Ratio
-7.59 -4.22 -3.92 -5.06
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.04 0.30 0.12 0.09
Quick Ratio
15.60 2.53 9.11 13.31
Current Ratio
15.60 2.53 9.11 13.31
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
n/a n/a -58.61 n/a
Return on Equity
-0.5 -2.58 -0.65 -0.41
Return on Assets
-0.46 -1.43 -0.54 -0.35
Return on Invested Capital
-0.53 -2.04 -0.58 -0.37
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a